TXRH 32.27 Texas Roadhouse $TXRH Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
TXRH 32.27 Texas Roadhouse $TXRH Hit a 52 week high of 32.34 Closing the day 09:44 at 32.27 -0.16 -0.49% With a day low of 32.08 and a total volume of 40,310.

TXRH Recent Posts: http://investorshangout.com/Texas-Roadhouse-Inc-TXRH-55717/

TXRH Texas Roadhouse Recent Headline News

Where's the Beef? Rising Prices Have Burger Joints Pushing Poultry
Rich Duprey, The Motley Fool - Motley Fool - Wed Nov 12, 1:00PM CST
It only took  Chipotle Mexican Grill  thinking out loud about dropping guacamole from its menu because of rising avocado prices to generate fear of a looming " guacalypse ." A world without the dip was apparently one not worth living in. The...
CMG: 671.14 (+0.39), MCD: 96.29 (+0.81), DPZ: 91.30 (-0.57), YUM: 74.64 (-0.75), WEN: 8.54 (+0.06), TXRH: 31.73 (-0.70), BKW: 32.30 (+0.26)

Texas Roadhouse Shares Up 23.8% Since SmarTrend's Buy Recommendation (TXRH)
Comtex SmarTrend(R) - Wed Nov 12, 11:03AM CST
SmarTrend identified an Uptrend for Texas Roadhouse (NASDAQ:TXRH) on June 5th, 2014 at $25.83. In approximately 5 months, Texas Roadhouse has returned 23.85% as of today's recent price of $31.99.
TXRH: 31.73 (-0.70)

4 Restaurant Stocks That Soared Last Week
Rick Munarriz, The Motley Fool - Motley Fool - Mon Nov 10, 4:11PM CST
The entire market has been rallying through earnings season, but some stocks have been faring a lot better than others. Several restaurant stocks soared last week, fueled by encouraging financial results.  Let's take a closer look at four publicly...
RRGB: 68.48 (-0.41), PBPB: 13.21 (-0.40), BLMN: 21.98 (+0.08), TXRH: 31.73 (-0.70)

The Best Small-Cap Dividend Growers: Cracker Barrel
Stan Stafford - at Seeking Alpha - Fri Nov 07, 1:57PM CST

CBRL: 120.42 (-0.22), DIN: 95.07 (+0.08), TXRH: 31.73 (-0.70)

Restaurants Technical Review - Starbucks, Yum! Brands, Arcos Dorados Holdings, Texas Roadhouse, and Panera Bread
PR Newswire - Thu Nov 06, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Starbucks Corporation (NASDAQ: SBUX), Yum! Brands Inc. (NYSE: YUM), Arcos Dorados Holdings Inc. (NYSE: ARCO), Texas Roadhouse Inc. (NASDAQ: TXRH), and Panera Bread Company (NASDAQ: PNRA). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, November 05, 2014, mostly ended on a higher note as the Dow Jones Industrial Average finished at 17,484.53, up 0.58% and the NASDAQ Composite closed at 4,620.72, down 0.06%. The S&P 500 finished the session 0.57% higher at 2,023.57. During the trading session, nine out of ten sectors finished on a positive note. The S&P 500 Consumer Discretionary Sector Index ended the day at 535.50, up 0.42%, with the index advancing 2.60% in the previous three months. Register for your complimentary reports on these five stocks at:
SBUX: 78.13 (+0.24), PNRA: 170.28 (+0.05), ARCO: 6.68 (unch), TXRH: 31.73 (-0.70), YUM: 74.64 (-0.75)

Update: Texas Roadhouse Reports Strong Third Quarter Results, Keeps Growing
Jonathan Weber - at Seeking Alpha - Wed Nov 05, 10:11AM CST

TXRH: 31.73 (-0.70)

Texas Roadhouse Has Returned 21.8% Since SmarTrend Recommendation (TXRH)
Comtex SmarTrend(R) - Wed Nov 05, 9:41AM CST
SmarTrend identified an Uptrend for Texas Roadhouse (NASDAQ:TXRH) on June 5th, 2014 at $25.83. In approximately 5 months, Texas Roadhouse has returned 21.84% as of today's recent price of $31.47.
TXRH: 31.73 (-0.70)

Texas Roadhouse (TXRH) in Focus: Adds 5.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 7:37AM CST
Texas Roadhouse, Inc. (TXRH) was a big mover last session, as the company saw its shares nearly 6% on the day.
JACK: 71.72 (-0.62), BJRI: 46.80 (+0.24), DIN: 95.07 (+0.08), TXRH: 31.73 (-0.70)

Stocks Narrow Losses; Airlines Lead
at Investor's Business Daily - Tue Nov 04, 12:29PM CST
Stocks narrowed losses near midday Tuesday, but some leaders remained under pressure. The Nasdaq fell 0.6%, the S&P 500 dropped 0.4%, and the Dow Jones industrial average was down a fraction. Wal-Mart Stores (WMT), Travelers (TRV) and Procter &...
LCI: 46.97 (-1.31), SAVE: 76.36 (-1.74), WMT: 82.85 (-0.09), PG: 87.99 (-0.61), ATHM: 44.58 (+1.59), TXRH: 31.73 (-0.70), LUV: 38.97 (-0.49), TRV: 102.25 (-0.98)

Update: Texas Roadhouse Earnings Q3 2014
ColoradoWealthManagementFund - at Seeking Alpha - Tue Nov 04, 8:24AM CST

TXRH: 31.73 (-0.70)

Texas Roadhouse Inc. Earnings: Steaks Are High
Rick Munarriz, The Motley Fool - Motley Fool - Mon Nov 03, 10:45PM CST
Source: Texas Roadhouse. Texas Roadhouse is hoping that it's not just its signature steaks that are meaty. The chain of 436 casual steakhouses posted quarterly results after Monday's market close. Revenue climbed 15% to $385.2 million as...
TXRH: 31.73 (-0.70)

Texas Roadhouse (TXRH) Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 03, 7:49PM CST

TXRH: 31.73 (-0.70)

Texas Roadhouse misses 3Q profit forecasts
Automated Insights - Mon Nov 03, 5:42PM CST
LOUISVILLE, Ky. (AP) _ Texas Roadhouse Inc. (TXRH) on Monday reported earnings of $18.9 million in its third quarter.
TXRH: 31.73 (-0.70)

Texas Roadhouse (TXRH) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 03, 3:55PM CST

TXRH: 31.73 (-0.70)

Texas Roadhouse cites strong comps to begin Q4
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 3:28PM CST

TXRH: 31.73 (-0.70)

Texas Roadhouse misses by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 3:19PM CST

TXRH: 31.73 (-0.70)

Texas Roadhouse, Inc. Announces Third Quarter 2014 Results
Business Wire - Mon Nov 03, 3:06PM CST
Texas Roadhouse, Inc. (NasdaqGS: TXRH), today announced financial results for the 13 and 39 week periods ended September 30, 2014.
TXRH: 31.73 (-0.70)

Food prices trek higher
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 11:01AM CDT

DFRG: 23.16 (-0.06), MOO: 54.67 (-0.08), PNRA: 170.28 (+0.05), BOBE: 53.01 (unch), EAT: 54.52 (-0.64), BWLD: 162.92 (-0.03), THI: 81.92 (+0.63), JACK: 71.72 (-0.62), SBUX: 78.13 (+0.24), DNKN: 47.94 (-0.58), NATH: 73.28 (+0.23), SONC: 25.20 (-0.22), IRG: 6.80 (-0.02), CAKE: 47.55 (-0.35), CMG: 671.14 (+0.39), PZZA: 49.90 (-0.25), DPZ: 91.30 (-0.57), KKD: 20.18 (+0.10), RUTH: 12.37 (unch), TXRH: 31.73 (-0.70), BDL: 23.35 (+0.45), RRGB: 68.48 (-0.41), DBA: 25.86 (-0.04), COW: 32.71 (+0.28), CHUY: 21.99 (-0.26), DIN: 95.07 (+0.08), DENN: 8.90 (+0.04), DRI: 55.91 (-0.39), BKW: 32.30 (+0.26), RT: 7.69 (+0.06), CBRL: 120.42 (-0.22), LUB: 4.82 (-0.04), MCD: 96.30 (+0.82), PAGG: 29.56 (-0.04), BBRG: 13.19 (+0.02), BLMN: 21.98 (+0.08), WEN: 8.54 (+0.06)

Why I Like Texas Roadhouse Over Panera
ColoradoWealthManagementFund - Seeking Alpha - Fri Oct 17, 2:30AM CDT
I like Panera (NASDAQ: PNRA ) as a restaurant, but I have recently soured a bit on them as an investment. In a recent article I laid out my case for Panera facing significant headwinds from operational problems. In short, the way Panera moves...
PNRA: 170.28 (+0.05), TXRH: 31.73 (-0.70)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading